ArticleCancer immunology research2021

KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1.

Rupal S Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.